Skip to main content
Medpace Holdings, Inc. logo

Medpace Holdings, Inc. — Investor Relations & Filings

Ticker · MEDP ISIN · US58506Q1094 LEI · 549300H8TYEUVTW14A54 US Professional, scientific and technical activities
Open in API
Filings indexed 859 across all filing types
Latest filing 2017-03-17 Director's Dealing
Country US United States of America
Listing US MEDP

About Medpace Holdings, Inc.

https://investor.medpace.com/

Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization (CRO) that provides Phase I-IV clinical development services. The company serves the biotechnology, pharmaceutical, and medical device industries, with a mission to accelerate the development of safe and effective medical therapeutics. Medpace employs a disciplined operating approach that leverages regulatory and therapeutic expertise. Its services include clinical pharmacology, central laboratory, bioanalytical, ECG core lab, and imaging core labs. The company has expertise across major therapeutic areas, including oncology, cardiology, metabolic disease, endocrinology, central nervous system, and anti-viral and anti-infective diseases.

Recent filings

Filing Released Lang Actions
FORM 4 SUBMISSION
Director's Dealing
2017-03-17 English
FORM 4 SUBMISSION
Director's Dealing
2017-03-17 English
FORM 4 SUBMISSION
Director's Dealing
2017-03-17 English
FORM 4 SUBMISSION
Director's Dealing
2017-03-17 English
10-K
Annual Report FY 2016
2017-02-28 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated February 28, 2017, by Medpace Holdings, Inc. The content focuses on announcing the date and details of the upcoming 2017 Annual Meeting of stockholders, including instructions for stockholders to submit nominations or business proposals. There is no financial data, earnings information, or detailed report content. The document is an announcement related to the Annual General Meeting but does not contain the meeting materials or presentations themselves. The document length is 2661 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this filing is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement that does not fit other specific categories like AGM Information or Proxy Solicitation.
2017-02-28 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.